ARCHIVES

Trials Approved In October

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

June 12, 1992

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

Report Criticizes NIH Grant Review

June 16, 1995

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012

In Brief: Sandor Eckhardt Is New UICC President; New Delhi Is Site Of 1994 UICC Meeting

August 31, 1990